TBR Nederland provides the following Reimbursement Schemes for the medicines below. No reimbursement is determined yet for these medicines, as a result of which you have to pay a personal contribution, or a personal contribution has been determined by the government.
The Personal Contribution that you have to pay for these medicines can be reimbursed through TBR Nederland. Below you will find more information about the relevant regulation per medicine. Want to know more about how to submit a claim? Read more
Important updates
-
Reimbursement Scheme Acecort®
27/02/2023
-
Reimbursement Scheme Forxiga® (dapagliflozine) 10 mg for the treatment of HFpEF (LVEF >40%)
27/02/2023
-
Reimbursement Scheme Isturisa®
16/06/2022
-
Termination TerugBetaalRegeling Forxiga® - Chronic Kidney Disease
28/04/2022
-
Extension to TerugBetaalRegeling Elvanse®
01/04/2022